Salvage Therapy with Vorinostat, Lenalidomide, and Dexamethasone (ZRD) in Lenalidomide/Dexamethasone Relapsed/Refractory Multiple Myeloma

被引：9
|
作者：
Richter, Joshua R. [1 ]
Bilotti, Elizabeth [1 ]
McBride, Laura [1 ]
Schmidt, Linda [1 ]
Gao, Zhijie [2 ]
Tufail, Madiha [2 ]
Anand, Palka [1 ]
McNeill, Ann [1 ]
Bednarz, Urszula [1 ]
Graef, Thorsten [3 ]
Vesole, David H. [1 ]
Siegel, David S. [1 ]
机构：
[1] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA
[2] Univ Med & Dent NJ, Newark, NJ USA
[3] Merck Res Labs, Upper Gwynedd, PA USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
10.1182/blood.V118.21.3986.3986
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1706 / 1706
页数：1
相关论文
共 50 条
  • [21] Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
    Stewart, A. Keith
    Rajkumar, S. Vincent
    Dimopoulos, Meletios A.
    Masszi, Tamas
    Spicka, Ivan
    Oriol, Albert
    Hajek, Roman
    Rosinol, Laura
    Siegel, David S.
    Mihaylov, Georgi G.
    Goranova-Marinova, Vesselina
    Rajnics, Peter
    Suvorov, Aleksandr
    Niesvizky, Ruben
    Jakubowiak, Andrzej J.
    San-Miguel, Jesus F.
    Ludwig, Heinz
    Wang, Michael
    Maisnar, Vladimr
    Minarik, Jiri
    Bensinger, William I.
    Mateos, Maria-Victoria
    Ben-Yehuda, Dina
    Kukreti, Vishal
    Zojwalla, Naseem
    Tonda, Margaret E.
    Yang, Xinqun
    Xing, Biao
    Moreau, Philippe
    Palumbo, Antonio
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (02): : 142 - 152
  • [22] Safety and Efficacy of Daratumumab with Lenalidomide and Dexamethasone in Relapsed or Relapsed, Refractory Multiple Myeloma
    Plesner, Torben
    Arkenau, Hendrik-Tobias
    Lokhorst, Henk M.
    Gimsing, Peter
    Krejcik, Jakub
    Lemech, Charlotte
    Minnema, Monique C.
    Lassen, Ulrik
    Laubach, Jacob P.
    Ahmadi, Tahamtan
    Yeh, Howard
    Guckert, Mary E.
    Feng, Huaibao
    Brun, Nikolai Constantin
    Lisby, Steen
    Basse, Linda
    Palumbo, Antonio
    Richardson, Paul G.
    BLOOD, 2014, 124 (21)
  • [23] SAFETY AND EFFICACY OF DARATUMUMAB WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED OR RELAPSED, REFRACTORY MULTIPLE MYELOMA
    Plesner, T.
    Arkenau, H. T.
    Lokhorst, H. M.
    Gimsing, P.
    Krejcik, J.
    Lemech, C.
    Minnema, M. C.
    Lassen, U.
    Ahmadi, T.
    Yeh, H.
    Guckert, M.
    Brun, N. C.
    Lisby, S.
    Basse, L.
    Palumbo, A.
    Richardson, P. G.
    HAEMATOLOGICA, 2014, 99 : 104 - 104
  • [24] CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN JAPANESE PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Ri, M.
    Suzuki, K.
    Chou, T.
    Sugiura, I.
    Takezako, N.
    Sunami, K.
    Ishida, T.
    Izumi, T.
    Ozaki, S.
    Iida, S.
    HAEMATOLOGICA, 2016, 101 : 787 - 788
  • [25] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
    Nikhil C Munshi
    Constantine Mitsiades
    Paul G Richardson
    Kenneth C Anderson
    Nature Clinical Practice Oncology, 2008, 5 : 374 - 375
  • [26] Patient eligibility for lenalidomide/dexamethasone treatment in relapsed/refractory multiple myeloma
    Palumbo, A.
    Dimopoulos, M.
    San Miguel, J.
    Harousseau, J. L.
    Attal, M.
    Hussein, M.
    Knop, S.
    Ludwig, H.
    Sonneveld, P.
    von Lilienfeld-Toal, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 97 - 97
  • [27] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma
    Munshi, Nikhil C.
    Mitsiades, Constantine
    Richardson, Paul G.
    Anderson, Kenneth C.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (07): : 374 - 375
  • [28] Relapsed multiple myeloma as TEMPI syndrome with good response to salvage lenalidomide and dexamethasone
    Shih-Hsin Liang
    Su-Peng Yeh
    Annals of Hematology, 2019, 98 : 2447 - 2450
  • [29] Relapsed multiple myeloma as TEMPI syndrome with good response to salvage lenalidomide and dexamethasone
    Liang, Shih-Hsin
    Yeh, Su-Peng
    ANNALS OF HEMATOLOGY, 2019, 98 (10) : 2447 - 2450
  • [30] Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma
    Stadtmauer, Edward A.
    Weber, Donna M.
    Niesvizky, Ruben
    Belch, Andrew
    Prince, Miles H.
    San Miguel, Jesus F.
    Facon, Thierry
    Olesnyckyj, Marta
    Yu, Zhinuan
    Zeldis, Jerome B.
    Knight, Robert D.
    Dimopoulos, Meletios A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (06) : 426 - 432
12345